Repository logo
 
Publication

[Smoking Cessation after Bladder Cancer Diagnosis]

2018-02-28Journal article Open access
Simple item page
dc.contributor.authorMota, P
dc.contributor.authorSousa, PM
dc.contributor.authorBotelho, F
dc.contributor.authorCarvalho-Dias, E
dc.contributor.authorCordeiro, A
dc.contributor.authorTorres, JP
dc.contributor.authorMorais, N
dc.contributor.authorAnacleto, S
dc.contributor.authorLima, E
dc.date.accessioned2018-04-13T13:42:56Z
dc.date.available2018-04-13T13:42:56Z
dc.date.issued2018-02-28
dc.description.abstractINTRODUCTION: Smoking is an important risk factor for the development, recurrence and progression of bladder cancer. Our aim was to analyze smoking habits after diagnosis in bladder cancer patients. Additionally, we evaluated patient knowledge about smoking as a risk factor and the urologist role in promoting abstinence. MATERIAL AND METHODS: A cross-sectional, observational and descriptive study was performed in bladder cancer patients, diagnosed between January 2013 and September 2015 (n = 160) in Braga Hospital, in Portugal. RESULTS: Smoking history was present in 71.9% of the sample, with 21.9% current smokers, (40.7% of abstinence after diagnosis). Smoking was acknowledged as a risk factor by 74.4% of the sample, with only 51.3% of ever smokers and 24.4% of non-smokers recognizing smoking as the leading risk factor (p = 0.008). The presence of other household smokers were significantly higher in patients who continued smoking (40%) than in ex-smokers after diagnosis (4.2%) (p = 0.005). The majority of smokers at diagnosis (83.1%) were advised to quit by their urologist, but only one smoker (1.7%) was offered any specific intervention to aid in cessation. DISCUSSION: Smoking is not recognized as the leading risk factor for bladder cancer. This limited awareness, associated with the known difficulties in quitting smoking and the observed lack of smoking cessation interventions, may account for the high current smoking prevalence, albeit in line with other studies. CONCLUSION: This study highlights the need for efficient smoking cessation programs directed to bladder cancer patients.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationActa Med Port. 2018 Feb 28;31(2):101-108.pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.23/1253
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.subjectCessação Tabágicapt_PT
dc.subjectNeoplasias da Bexigapt_PT
dc.subjectTabagismopt_PT
dc.title[Smoking Cessation after Bladder Cancer Diagnosis]pt_PT
dc.title.alternativeCessação Tabágica após o Diagnóstico de Cancro da Bexigapt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue2pt_PT
oaire.citation.startPage101-108pt_PT
oaire.citation.volume31pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
Smoking.pdf
Size:
503.23 KB
Format:
Adobe Portable Document Format
Download
Thumbnail Image
Name:
Smoking2.pdf
Size:
202.53 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

HB - UR - Artigos
CCA - Artigos